SAB BIOTHERAPEUTICS, INC. (SABS) Operating cash flow 2020–2025
SAB BIOTHERAPEUTICS, INC. (SABS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$44.8MFY2025 · since FY2020: $10.0M → -$44.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$44.8M | -30.6% |
| FY2024 | -$34.3M | -36.5% |
| FY2023 | -$25.1M | -7.1% |
| FY2022 | -$23.5M | -1280.7% |
| FY2021 | $2.0M | -80.1% |
| FY2020 | $10.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SABS financial trends
SABS RevenueSABS Net incomeSABS Net marginSABS Gross profitSABS Gross marginSABS Operating incomeSABS Operating marginSABS Free cash flowSABS Capital expendituresSABS Return on equitySABS Stock buybacksSABS Dividends paidSABS Total assetsSABS Total liabilitiesSABS Shareholders’ equitySABS overview →